Lymphoma Research Foundation Announces Sonali M Smith, MD as Scientific Advisory Board Chair prweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prweb.com Daily Mail and Mail on Sunday newspapers.
Lymphoma Research Foundation Honors Michael E. Williams, MD with Mantle Cell Lymphoma Leadership Award
Share Article
World-Renowned Hematologist/Oncologist Receives Inaugural Award for Outstanding Commitment in the Field of Mantle Cell Lymphoma Research and Patient Care
Dr. Williams contributions to the LRF Mantle Cell Lymphoma Consortium have informed LRF’s education programming and resources for patients and led to the growth of the Foundation’s MCL research program. NEW YORK (PRWEB) April 08, 2021
The Lymphoma Research Foundation (LRF) – the nation’s largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma community through a comprehensive series of education programs, outreach initiatives, and patient services – presented the inaugural Mantle Cell Lymphoma Leadership Award to Michael E. Williams, MD, Professor of Medicine, and Associate Di
Of 192 study participants who received Breyanzi, 73% achieved a response, including 54% who had minimal or no detectable lymphoma remaining following treatment and 19% who achieved a partial response.<br />
FDA Approves Umbralisib (Ukoniq) for Two Lymphomas medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
Global biopharmaceutical company Bristol Myers Squibb (BMS) has received US Food and Drug Administration (USFDA) approval for its new CD19-directed chimeric antigen receptor (CAR) T cell therapy Breyanzi (lisocabtagene maraleucel; liso-cel).